Azenta Q4'22 Earnings Release Conference Call and Webcast
November 14, 2022 at 4:30 PM EDT
5th Annual Evercore ISI HealthCONx Conference
November 29, 2022 at 3:30 PM EDT
Learn more about our recent acquisition of B Medical Systems, a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe.
View our latest investor presentation
Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.
Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into an accelerated share repurchase agreement ("ASR") with JP Morgan Chase Bank, N.A. (the "Dealer") to repurchase $500 million of...
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, which includes a...
Delivered on Expected Q4'22 Revenue of $138 million Strong Double-Digit Organic Growth Excluding COVID for Q4 and Full Fiscal Year Plan to Repurchase at Least $1 Billion of Common Stock Over the...
Q4 2022 Earnings Call Presentation
Dial in: 800-936-4761
Head of Investor Relations
Executive Assistant to CFO
P.O. Box 43006
Providence RI 02940-3006
Investor Center web address:
SIGN UP FOR ALERTS AND NEVER MISS INVESTOR UPDATES!